Intrauterine Devices Market By Product Type (Hormonal Intrauterine Device and Copper Intrauterine Device), By Material (Plastic, Copper and Hormonal (Levonorgestrel)), By Age Group (15-24 years, 25-34 years, 35-44 years and Above 44 years), By End-user (Hospital, Gynecology Clinics, Community Health Care Centers and Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Oct 2024 | Report ID: MI1116 | 210 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

Report Coverage:

By Product Type

  • Hormonal Intrauterine Device
  • Copper Intrauterine Device

By Material                  

  • Plastic
  • Copper
  • Hormonal (Levonorgestrel)

By Age Group

  • 15-24 years
  • 25-34 years
  • 35-44 years
  • Above 44 years

End-user  

  • Hospital
  • Gynecology Clinics
  • Community Health Care Centers
  • Others

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

List of Companies:

  • Bayer AG
  • CooperSurgical, Inc.
  • Merck & Co., Inc.
  • Teleflex Incorporated
  • Hologic, Inc.
  • TOLMAR Pharmaceuticals, Inc.
  • Nusil Age Group  LLC
  • Medicraft Limited
  • Ethypharm
  • Ferring Pharmaceuticals
  • VivaSight
  • HLL Lifecare Limited
  • Suhar International
  • Screaming Eagle, LLC
  • AstraZeneca PLC

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing